Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,341,958 papers from all fields of science
Search
Sign In
Create Free Account
Radiology studies
Known as:
radiology test
, Radiology
, RAD
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
50 relations
3D printed model:Find:Pt:XXX:Doc:MR
Courtesy consultation.XXX:Find:Pt:XXX:Doc
Guidance for ablation of tissue:Find:Pt:XXX:Doc:CT
Guidance for ablation of tissue:Find:Pt:XXX:Doc:US
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Transport Properties of Puerarin and Effect of Extract of Radix Angelicae dahuricae on Puerarin Intestinal Absorption Using In Situ and In Vitro Models
Zheng-gen Liao
,
Xinli Liang
,
+4 authors
Li-Jun Zhao
Phytotherapy Research
2014
Corpus ID: 23509657
The root of Angelica dahurica (Radix Angelicae Dahuricae, RAD), which contains coumarins and volatile oil as its main classes of…
Expand
2006
2006
Everolimus (RAD) Inhibits In Vivo Growth of Murine Squamous Cell Carcinoma (SCC VII)
S. Khariwala
,
J. Kjaergaard
,
R. Lorenz
,
F. van Lente
,
S. Shu
,
M. Strome
The Laryngoscope
2006
Corpus ID: 33764577
Objective: Everolimus (RAD) is an mTOR inhibitor closely related to rapamycin. A potent immunosuppressive agent, it has also…
Expand
2004
2004
The Impact of Public Funding on Private RaD investment. New Evidence from a Firm Level Innovation Study (Additionality or Crowding Out? On the effectiveness of RaD subsidies)
Hans Lööf
,
Almas Hesmati
2004
Corpus ID: 152700558
This paper investigates the effectiveness of a public innovation policy aimed at stimulating private R&D investment. The research…
Expand
2000
2000
Pharmacokinetics of SDZ RAD and cyclosporin including their metabolites in seven kidney graft patients after the first dose of SDZ RAD.
Gabriele I. Kirchner
,
Michael Winkler
,
+7 authors
Karl-Friedrich Sewing
British Journal of Clinical Pharmacology
2000
Corpus ID: 6033895
AIMS The aim of the study was to investigate the pharmacokinetics and metabolism of the new immunosuppressant SDZ RAD during…
Expand
2000
2000
The peripheral lymphocyte count predicts graft survival in DA to Lewis heterotopic heart transplantation treated with FTY720 and SDZ RAD.
Zariana Nikolova
,
A. Hof
,
Y. Baumlin
,
Robert P. Hof
Transplant Immunology
2000
Corpus ID: 45833249
2000
2000
COADMINISTRATION OF THE NEW MACROLIDE IMMUNOSUPPRESSANT RAD AND MYCOPHENOLATE MOFETIL IN EXPERIMENTAL CORNEAL TRANSPLANTATION
A. Reis
,
Mosaad Megahed
,
+4 authors
R. Sundmacher
Transplantation
2000
Corpus ID: 425313
Introduction. The effect of RAD, a new macrolide immunosuppressant, was examined as mono- and combination therapy with…
Expand
2000
2000
The novel immunosuppressant FTY720 induces peripheral lymphodepletion of both T- and B-cells in cynomolgus monkeys when given alone, with Cyclosporine Neoral or with RAD.
V. Quesniaux
,
K. Menninger
,
+5 authors
H. Schuurman
Transplant Immunology
2000
Corpus ID: 7427890
Highly Cited
1999
Highly Cited
1999
SDZ RAD inhibits cold ischemia-induced vascular remodeling.
H. Schuurman
,
C. Pally
,
G. Weckbecker
,
Walter Schuler
,
Christopher M. Bruns
Transplantation Proceedings
1999
Corpus ID: 43218319
Highly Cited
1999
Highly Cited
1999
Suppression of acute rejection in allogeneic rat lung transplantation: a study of the efficacy and pharmacokinetics of rapamycin derivative (SDZ RAD) used alone and in combination with a…
B. Hausen
,
K. Boeke
,
+4 authors
R. Morris
The Journal of Heart and Lung Transplantation
1999
Corpus ID: 31892994
1982
1982
4,000 RAD preoperative irradiation followed by prompt radical cystectomy for invasive bladder carcinoma: a prospective study of patient tolerance and pathologic downstaging.
W. Shipley
,
K. Cummings
,
L. Coombs
,
I. Hawkins
,
A. Einstein
,
G. Penick
Journal of Urology
1982
Corpus ID: 23087732
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE